Universal Sequencing Technology Corporation (dba UST Corporation) is an innovative U.S. based biotechnology company based in Greater Boston, MA and San Diego, CA. UST is dedicated to the development of the most advanced, accurate and cost effective DNA/RNA sequencing technologies. We developed an NGS transposase based TELL-Seq linked read library prep kit technology. TELL-Seq enables short read 2nd generation sequencing platforms, such as Illumina sequencers, to produce super long read results (average 40kb, up to 200kb or longer). It is accurate and cost effective. The process is simple and fast. A sequencing ready Illumina library can be prepared in a PCR tube in 3 hours. It requires ultra low DNA input, 0.1-0.5ng for bacteria and target sequencing panels, and 3-5ng for whole human genomes. This is commercially available. Reach out to me for more information at [email protected]
New promotion for 50% off - https://www.universalsequencing.com/promotion
-
New NGS Vendor in South America (Universal Sequencing)
Last edited by jentschmidt; 07-13-2022, 11:51 AM.
-
NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...10-30-2026, 06:46 AM -
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM